|
Coverage Includes:
- Incorporating assay development into an overall biomarker strategy
- Multiplexed biomarker assays
- Fit-for-purpose assay development
- Total vs. free analyte quantification
- In-house assay development vs. off-the-shelf solutions vs. outsourcing
- Translation from in-house development to clinical laboratory
- Assay development for genomic and proteomic biomarkers
- Circulating cell assays
- Novel detection technologies
|
|